Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Infrared Coagulator (IRC) Ablation Versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Adults

NCT01164722 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT01164722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01164722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Infrared Coagulator (IRC) Ablation Versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Adults
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
July 31, 2016
Enrollment
120 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, neoplasm of uncertain malignant potential, nonneoplastic condition, precancerous condition